文献速递颈动脉与弓上血管

颈动脉支架置入术围手术期临床结局的解剖与技术预测因素

Anatomical and technical predictors of perioperative clinical outcomes after carotid artery stenting.
PubMed 文献 · J Vasc Surg · 2017-05-27

该回顾性分析纳入409例颈动脉支架置入术患者,发现MAE率为4.7%,卒中率为2.2%。重度钙化病变、栓塞保护装置置入前球囊扩张及支架后球囊扩张与较高卒中或MAE率相关,而ACCUNET栓塞保护装置与较低MAE率相关。

要点

  • 重度钙化病变患者卒中率6.3%,显著高于轻度/无钙化者的1.2%。
  • 栓塞保护装置置入前球囊扩张者卒中率9.1%,无此操作者为1.8%。
  • 使用ACCUNET栓塞保护装置者MAE率1.9%,其他装置为6.7%。

核心结论

  • 钙化病变及栓塞保护装置置入前或支架后球囊扩张与较高卒中或MAE率相关。
  • ACCUNET栓塞保护装置与较低MAE率相关。
  • 其他解剖/技术变量与CAS结局无显著相关性。

研究设计与样本

  • 回顾性分析前瞻性收集的409例(共456例)接受CAS的患者数据。
  • 采用逻辑回归分析解剖和技术因素对围手术期卒中、死亡和心肌梗死(MAE)的影响。

主要发现

  • 总体MAE率为4.7%(19/409),卒中率为2.2%(9/409)。

临床怎么用

  • 对于重度钙化病变或需在EPD置入前/支架后行球囊扩张的患者,应警惕较高的围手术期卒中或MAE风险。
  • 选择栓塞保护装置时,ACCUNET可能与较低的MAE率相关。

局限性

  • 回顾性分析设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A few other studies have reported the effects of anatomical and technical factors on clinical outcomes of carotid artery stenting (CAS). This study analyzed the effect of these factors on perioperative stroke/myocardial infarction/death after CAS. METHODS: This was a retrospective analysis of prospectively collected data of 409 of 456 patients who underwent CAS during the study period. A logistic regression analysis was used to determine the effects of anatomical and technical factors on perioperative stroke, death, and myocardial infarction (major adverse events [MAEs]). RESULTS: The MAE rate for the entire series was 4.7% (19 of 409), and the stroke rate was 2.2% (9 of 409). The stroke rate for asymptomatic patients was 0.46% (1 of 218; P = .01). The MAE rates for patients with transient ischemic attack (TIA) were 7% (11 of 158) vs 3.2% (8 of 251) for other indications (P = .077). The stroke rates for heavily calcified lesions were 6.3% (3 of 48) vs 1.2% (4 of 332) for mildly calcified/noncalcified lesions (P = .046). Differences in stroke and MAE rates regarding other anatomical features were not significant. The stroke rate for patients with percutaneous transluminal angioplasty (PTA) before embolic protection device (EPD) insertion was 9.1% (2 of 22) vs 1.8% (7 of 387) for patients without (P = .07) and 2.6% (9 of 341) for patients with poststenting PTA vs 0% (0 of 68) for patients without. The MAE rate for patients with poststenting PTA was 5.6% (19 of 341) vs 0% (0 of 68) for patients without (P = .0536). The MAE rate for patients with the ACCUNET (Abbott, Abbott Park, Ill) EPD was 1.9% (3 of 158) vs 6.7% (16 of 240) for others (P = .029). The differences between stroke and MAE rates for other technical features were not significant. A regression analysis showed that the odds ratio for stroke was 0.1 (P = .031) for asymptomatic indications, 13.7 (P = .014) for TIA indications, 6.1 (P = .0303) for PTA performed before EPD insertion, 1.7 for PTA performed before stenting, and 5.4 (P = .0315) for heavily calcified lesions. The MAE odds ratio was 0.46 (P = .0858) for asymptomatic indications, 2.1 for PTAs performed before EPD insertion, 2.2 for poststent PTAs, and 2.2 (P = .1888) for heavily calcified lesions. A multivariate analysis showed that patients with TIA had an odds ratio of stroke of 11.05 (P = .029). Patients with PTAs performed before EPD insertion had an OR of 6.15 (P = .062). Patients with heavily calcified lesions had an odds ratio of stroke of 4.25 (P = .0871). The MAE odds ratio for ACCUNET vs others was 0.27 (P = .0389). CONCLUSIONS: Calcific lesions and PTA before EPD insertion or after stenting were associated with higher stroke or MAE rates, or both. The ACCUNET EPD was associated with lower MAE rates. There was no correlation between other anatomical/technical variables and CAS outcome.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. AbuRahma AF, DerDerian T, Hariri N, et al. Anatomical and technical predictors of perioperative clinical outcomes after carotid artery stenting. J Vasc Surg. 2017. PMID: 28559171. doi:10.1016/j.jvs.2017.02.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。